blog:bpaddock:mri_contrast_gadolinium_toxicity

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Next revision
Previous revision
Both sides next revision
blog:bpaddock:mri_contrast_gadolinium_toxicity [2014/07/06 23:50]
bpaddock MRI Contrast Gadolinium Toxicity
blog:bpaddock:mri_contrast_gadolinium_toxicity [2017/03/11 02:53]
bpaddock
Line 1: Line 1:
 ====== MRI Contrast Gadolinium Toxicity ====== ====== MRI Contrast Gadolinium Toxicity ======
  
 +European regulators want some forms of Gadolinium contrast agents pulled from the market.
 +
 +PRAC concludes assessment of gadolinium agents used in
 +body scans and recommends regulatory actions, including
 +suspension for some marketing authorisations.
 +
 +The linear gadolinium products gadobenic acid, gadopentetic acid, gadodiamide, and gadoversetamide. 
 +
 +http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/03/news_detail_002708.jsp&mid=WC0b01ac058004d5c1
 +
 +http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2017/03/WC500223209.pdf
  
 {{page>:tips:gadolinium}} {{page>:tips:gadolinium}}
  • blog/bpaddock/mri_contrast_gadolinium_toxicity.txt
  • Last modified: 2017/03/11 02:53
  • (external edit)